An analysis of clinical characteristics in genetically linked migraine-affected pedigrees

Cephalalgia

Volumn 23, Issue 8, 2003, Pages 808-813

  Lea, R A ^a   Hilton, D A ^a   MacMillian, J C ^b   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b NONE

Author keywords

Clinical association; Genetic; Migraine; Pedigree

Indexed keywords

ADOLESCENT; ADULT; ANALYSIS; ARTICLE; CHILD; CHROMOSOME 19; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FAMILY; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ONSET AGE; PEDIGREE; SEX DIFFERENCE; SYMPTOM; X CHROMOSOME LINKAGE;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PEDIGREE; SEX CHARACTERISTICS; STATISTICS, NONPARAMETRIC;

EID: 0141959072     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00578.x     Document Type: Article

References (12)

1. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort - The GEM Study. Neurology 1999; 53:537-42.
2. Russell M, Olesen J. Increased familial risk and evidence of genetic factors in migraine. Br Med J 1995; 311:541-4.
3. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Grifiths LR. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology 1998; 50:1428-32.
4. Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: significant linkage and localization of gene to Xq24-28. Hum Genet 2000; 107:18-23.
5. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997; 49:201-6.
6. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998; 51:781-6.
7. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000; 96:762-4.
8. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000; 43:133-6.
9. Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 2002; 42:893-5.
10. Nyholt DR, Gillespie NA, Heath AC, Merikangas KR, Duffy DL, Martin NG. Latent class analysis does not support migraine with aura and migraine without aura as separate entities. Ann Neurol, under review.
11. Blau JN. Migraine prodromes separated from the aura: complete migraine. Br Med J 1980; 281:658-60.
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):19-28.